Changes of PVS ratios and volumes for different treatment periods and different dose levels (HD: high dose, SD: standard dose, and RD: reduced dose). by Ruitian Song (11045127)

Subjects:

Descriptive statistics. by Amit Timilsina (15203538)

Subjects:

The dataset for the full model analysis. by Ruitian Song (11045127)

Subjects:

Pseudocode of the simulation program (see Supplementary Materials for <i>R</i> codes S1 File). by Farrokh Habibzadeh (12256529)

Subjects:

Significant cholesterol genes arranged by day. by Katherine M. Peterson (19746455)

“…Genes with increased expression are blue; genes with decreased expression are orange; the depth of color reflects the magnitude of the increase or decrease. …”

Ydj1 acetylation alters interactions with client proteins. by Siddhi Omkar (12413434)

“…Interactors are colored according to change in interaction as follows: green (significant increase), red (significant decrease), or purple (no significant change) 6KQ/6KR. …”

Results of differential abundance assessment expressed as Log2 Fold Change (Log2FC) for comparison between different taxonomic groups after the intervention. by Adriana Bittencourt Campaner (21175462)

Comprehensive evaluation index system of EDI. by Yuanzhi Guo (16624797)

Subjects:

Moran’s <i>I</i> of China’s educational development from 2003 to 2020. by Yuanzhi Guo (16624797)

Subjects:

Changes of anti-oxidative enzyme and oxidative stress after in a mouse model of kidney fibrosis. by Wencheng Jin (13136262)

Subjects:

New visits, types of health events, procedure, and outcome of health events during all of 2020, and during the BR-period, Ramadan period, and AR-period. by Taizo Sakata (21567847)

Subjects:

Changes related to kidney staining in UUO mouse model. by Wencheng Jin (13136262)

Subjects:

Flow diagram of participant selection. by Prajwal Paudel (7359209)

Subjects:

Results of <i>LM</i> test, <i>LR</i> test, <i>Wald</i> test and <i>Hausman</i> test. by Yuanzhi Guo (16624797)

Subjects:

Changes associated with kidney fibrosis and effects of MN705 treatment on TGF- by Wencheng Jin (13136262)

Subjects:

Age and sex of patients who visited the PHC during all of 2020, and during the BR-period, Ramadan period, and AR-period. by Taizo Sakata (21567847)

Subjects:

The screening process of MN705. by Wencheng Jin (13136262)

Subjects:

Provincial educational development level in China from 2003 to 2020. by Yuanzhi Guo (16624797)

Subjects:

Estimation results of spatial Durbin panel data model by regions. by Yuanzhi Guo (16624797)

Subjects:

The results of robust tests. by Yuanzhi Guo (16624797)

Subjects: